Evaluating amphiregulin in plasma for metastatic colorectal cancer treated with cetuximab based therapy.

Trial Profile

Evaluating amphiregulin in plasma for metastatic colorectal cancer treated with cetuximab based therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Cetuximab (Primary) ; Irinotecan (Primary) ; Amphiregulin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2016 Status changed from recruiting to completed.
    • 28 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top